|
|
|
MIRA INFORM REPORT
|
Report No. : |
508836 |
|
Report Date : |
14.05.2018 |
IDENTIFICATION DETAILS
|
Name : |
MEDISPRAY LABORATORIES PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
Plot No. 344/345, Kundaim Industrial Estate, Kundaim – 403115, Goa |
|
Tel. No.: |
91-832-2395656 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2016 |
|
|
|
|
Date of
Incorporation : |
21.02.1992 |
|
|
|
|
Com. Reg. No.: |
24-002801 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
INR 0.510 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U52311GA1992PTC002801 |
|
|
|
|
IEC No.: [Import-Export Code No.] |
0397042132 |
|
|
|
|
GSTN : [Goods & Service Tax
Registration No.] |
30AAACM4153B1ZB |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
Not Available |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACM4153B |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer of pharmaceutical products. [Registered Activity] |
|
|
|
|
No. of Employees
: |
Information denied by the management |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A+ |
|
Credit Rating |
Explanation |
Rating Comments |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
Status : |
Excellent |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a subsidiary of “Meditab Specialities Private Limited” and
incorporated in the year 1992 and it is having good track records. As per Registrar of companies the date of balance sheet (i.e.
financial filed) is shown as 31.03.2017 but the documents related to the
financial for the year 2017 are not available from any sources. For the financial year 2016, the company has increased in its revenue
from operations as compared to previous year and maintained decent
profitability margin of 14.15%. Rating takes into consideration sound financial profile of the company
marked by healthy networth base and negligible debt balance sheet. Further, rating also derives strength from its strong holding company
support, vast experience of the promoters in the field of pharmaceutical
industry, established track record of business operations along with market
position and improvement in the revenue as well profitability profile during
the year. However, ratings strength is partially offset by intense competition from
industry. Trade relations are reported as fair. Business is active. Payment
terms are seems to be regular. In view of the aforesaid, the company can be considered for business
dealings at usual trade terms and conditions. |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
EXTERNAL AGENCY RATING
NOT AVAILABLE
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2018
BIFR (Board for Industrial & Financial Reconstruction) LISTING
STATUS
Subject’s name is not listed as a Sick Unit in
the publicly available BIFR (Board for Industrial & Financial
Reconstruction) list as of 14.05.2018
IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS
Subject’s name is not listed in the publicly
available IBBI (Insolvency and Bankruptcy Board of India) list as of report
date.
INFORMATION DENIED BY
|
Name : |
Mr. Shailendra Jagtap |
|
Designation : |
Manager |
|
Contact No.: |
91-9922407238 |
|
Date : |
12.05.2018 |
Management Non-Cooperative (91-832-2395656)
LOCATIONS
|
Registered Office : |
Plot No. 344/345, Kundaim Industrial Estate, Kundaim – 403115, Goa,
India |
|
Tel. No.: |
91-832-2395656/2395184 / 2394354 |
|
Fax No.: |
Not Available |
|
E-Mail : |
|
|
|
|
|
Factory : |
Located at : ·
Goa |
DIRECTORS
AS ON 31.03.2018
|
Name : |
Mr. Rajesh Dinkar Sawant |
|
Designation : |
Director |
|
Address : |
14, Okasa Residential Complex, Friends Colony, Kharpabadh, Ponda –
403401, Goa, India |
|
Date of Birth/Age : |
23.12.1967 |
|
Date of Appointment : |
01.12.2005 |
|
DIN No.: |
00380168 |
|
|
|
|
Name : |
Mr. Raman Parameswaran Athipotta |
|
Designation : |
Director |
|
Address : |
Pride, Flat No.202, 2nd Floor, 7 Bunglows, Versova, Andheri, Mumbai – 400061, Maharashtra, India |
|
Date of Appointment : |
18.03.2016 |
|
DIN No.: |
00025481 |
|
|
|
|
Name : |
Mr. Chandrashekhar V Ramachandran Iyer |
|
Designation : |
Director |
|
Address : |
B7/701, Green Acres II CHS, Off GB Road, Near Vijay Nagari, Waghbil, Thane – 400601, Maharashtra, India |
|
Date of Appointment : |
18.03.2016 |
|
DIN No.: |
07173310 |
KEY EXECUTIVES
|
Name : |
Mr. Shailendra Jagtap |
|
Designation : |
Manager |
|
|
|
|
Name : |
Mr. Prashant |
|
Designation : |
Accounts Manager |
MAJOR SHAREHOLDERS
AS ON 31.03.2017
|
Names of Shareholders |
No. of Shares |
|
Meditab Specialities Private Limited, India |
51014 |
|
M K. Hamied Jointly With Meditab Specialities Private Limited, India |
1 |
|
Kamil Hamied Jointly With Meditab Specialities Private Limited, India |
1 |
|
S Radhakrishnan Jointly With Meditab Specialities Private Limited,
India |
1 |
|
R. Gopalakrishnan Jointly With Meditab Specialities Private Limited,
India |
1 |
|
Mital Sanghvi Jointly With Meditab Specialities Private Limited, India |
1 |
|
A P Raman Jointly With Meditab Specialities Private Limited, India |
1 |
|
|
|
|
Total |
51020 |
Equity Share Break up (Percentage of Total Equity)
AS ON 30.09.2017
|
Category |
Percentage |
|
Promoters [Bodies
corporate] |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of pharmaceutical products. [Registered Activity] |
||||
|
|
|
||||
|
Products / Services
: |
|
||||
|
|
|
||||
|
Brand Names : |
Not Available |
||||
|
|
|
||||
|
Agencies Held : |
Not Available |
||||
|
|
|
||||
|
Exports : |
Not Divulged |
||||
|
|
|
||||
|
Imports : |
Not Divulged |
||||
|
|
|
||||
|
Terms : |
Not Divulged |
PRODUCTION STATUS – (NOT AVAILABLE)
GENERAL INFORMATION
|
Suppliers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Customers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
No. of Employees : |
Information denied by the management |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Bankers : |
|
|
Auditors : |
|
|
Name : |
V. Sankar Aiyer and Company Chartered Accountants |
|
Address : |
2-C, Court Chambers, 35 New Marine Lines, Mumbai – 400020,
Maharashtra, India |
|
PAN No.: |
AAAFV0781D |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Ultimate Holding
Company : |
· Cipla Limited |
|
|
|
|
Holding Company : |
· Meditab Specialities Private Limited |
|
|
|
|
Fellow Subsidiaries
: |
· Cipla FZE · Golden Cross Pharma Private Limited · Cipla (Mauritius) Limited · Cipla Medpro South Africa Proprietary Limited · Cipla Holding B.V. · Cipla (UK) Limited · Cipla Australia Pty. Limited · Cipla (EU) Limited · Sitec Labs Private Limited · Four M Propack Private Limited · Cipla BioTec Private Limited (Formerly Known as Mabpharm Private Limited) · Jay Precision Pharmaceuticals Private Limited · Saba Investment Limited · Meditab Holdings Limited, Mauritius · Meditab Pharmaceuticals South Africa (Pty) Limited (De-registered on 14th August 2015) · Meditab Specialities New Zealand Limited · Cipla USA Inc. · Cipla Kenya Limited · Cipla Malaysia Sdn. Bhd. · Cipla Europe NV · Cipla Quality Chemical Industries Limited · Celeris d.o.o · Cipla Medpro Manufacturing Proprietary Limited (De-registered on 16th September 2015) · Galilee Marketting Proprietary Limited · Inyanga Trading 386 Proprietary Limited · Xeragen Laboratories Proprietary Limited · Cipla Medpro Holdings Proprietary Limited · Cape to carlo Exports Proprietary Limited · Cipla Agrimed Proprietary Limited · Cipla Dibcare proprietary Limited · Cipla Health care Proprietary Limited (De-registered on 28th October 2015) · Cipla Life Science Proprietary Limited · Cipla-Medpro Proprietary Limited · Cipla-Medpro Distribution Centre Proprietary Limited · Cipla Medpro ARV Proprietary Limited · Cipla Medpro Botswana Proprietary Limited · Cipla Medpro Cardio Respiratory Proprietary Limited (De-registered on 16th September 2015) · Cipla Medpro Research and Development Proprietary Limited · Cipla Nutrition Proprietary Limited (Buy Back of shares on 1st October 2015) · Cipla Personal Care Proprietary Limited · Cipla vet Proprietary Limited · Gardian Cipla Proprietary limited (De-registered on 20th January 2016) · Medpro Gen Proprietary Limited (De-registered on 16th September 2015) · Medpro Holdings proprietary Limited (De-registered on 16th September 2015) · Medpro Pharmaceutica Proprietary Limited · Medpro Pharmaceutica Africa Proprietary Limited (De-registered on 16th September 2015) · Medpro-On-Line Proprietary Limited (De-registered on 16th September 2015) · Med Man Care Proprietary Limited · Smith and Couzin Proprietary Limited (De-registered on 16th September 2015) · Breathe Free Lanka (Private) Limited · Cipla Brasil Importadore E Distribuidora De Medicamentos Ltda (w.e.f. 11th May 2015) · Cipla Maroc SA (w.e.f. 11th May 2015) · Cipla Middle East Pharmacueticals FZ-LLC (w.e.f. 31st May 2015) · Quality Chemicals Limited (w.e.f. 6th August 2015) · Cipla Phillippines Inc. (w.e.f. 6th January 2016) · InvaGen Pharmaceuticals Inc. (w.e.f. 17th February 2016) · Exelan Pharmaceuticals Inc. (w.e.f. 17th February 2016) · Cipla Health Limited (w.e.f. 27th August 2015) · Cipla Croatia d.o.o., Croatia · Cipla Canada Inc., Canada · Medica Pharmaceuticals Industries Company Limited, Yemen · Al-Jabal For Drugs and Medical Appliances company Limited, Yemen · Cipla Pharma Lanka (Private) Limited, Sri Lanka · Cipla Pharma Nigeria Limited, Nigeria |
CAPITAL STRUCTURE
AS ON 30.09.2017
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
100000 |
Equity Shares |
INR 10/- each |
INR 1.000 Million |
|
500000 |
Preferences Shares |
INR 100/- each |
INR 50.000 Million |
|
|
|
|
|
|
|
TOTAL
|
|
INR 51.000
Million |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
51020 |
Equity Shares |
INR 10/- each |
INR 0.510
Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in INR Million]
ABRIDGED
BALANCE SHEET
|
SOURCES OF FUNDS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
0.510 |
0.510 |
0.510 |
|
(b) Reserves and Surplus |
1529.899 |
1115.296 |
822.090 |
|
(c) Money
received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money pending
allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
1530.409 |
1115.806 |
822.600 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
0.000 |
0.000 |
0.000 |
|
(b) Deferred tax liabilities (Net) |
0.000 |
0.000 |
0.000 |
|
(c) Other long-term
liabilities |
0.000 |
0.000 |
0.000 |
|
(d) long-term
provisions |
42.830 |
32.047 |
4.875 |
|
Total Non-current
Liabilities (3) |
42.830 |
32.047 |
4.875 |
|
|
|
|
|
|
(4) Current
Liabilities |
|
|
|
|
(a) Short-term
borrowings |
50.000 |
120.000 |
0.000 |
|
(b) Trade
payables |
489.822 |
750.178 |
128.669 |
|
(c) Other
current liabilities |
123.958 |
66.148 |
4.688 |
|
(d) Short-term
provisions |
4.539 |
8.435 |
0.798 |
|
Total Current
Liabilities (4) |
668.319 |
944.761 |
134.155 |
|
|
|
|
|
|
TOTAL |
2241.558 |
2092.614 |
961.630 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1)
Non-current assets |
|
|
|
|
(a) Fixed
Assets |
|
|
|
|
(i)
Tangible assets |
715.717 |
557.922 |
57.302 |
|
(ii)
Intangible Assets |
11.097 |
19.819 |
0.000 |
|
(iii) Tangible assets
capital work-in-progress |
41.791 |
55.684 |
6.724 |
|
(iv)
Intangible assets under development |
0.000 |
0.000 |
2.071 |
|
(b) Non-current Investments |
7.383 |
7.812 |
2.751 |
|
(c) Deferred tax assets (net) |
25.643 |
8.622 |
0.669 |
|
(d)
Long-term loans and advances |
277.958 |
211.946 |
89.624 |
|
(e) Other
Non-current assets |
15.367 |
15.119 |
12.724 |
|
Total Non-Current
Assets |
1094.956 |
876.924 |
171.865 |
|
|
|
|
|
|
(2)
Current assets |
|
|
|
|
(a)
Current investments |
0.000 |
0.000 |
520.952 |
|
(b)
Inventories |
484.691 |
342.435 |
81.085 |
|
(c) Trade
receivables |
559.792 |
707.713 |
95.231 |
|
(d) Cash and
bank balances |
38.908 |
127.069 |
8.668 |
|
(e)
Short-term loans and advances |
38.813 |
33.765 |
83.829 |
|
(f) Other
current assets |
24.398 |
4.708 |
0.000 |
|
Total
Current Assets |
1146.602 |
1215.690 |
789.765 |
|
|
|
|
|
|
TOTAL |
2241.558 |
2092.614 |
961.630 |
PROFIT
& LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
|
SALES |
|
|
|
|
|
Total
Revenue from operations |
2931.009 |
1093.759 |
681.352 |
|
|
Other Income |
17.723 |
62.263 |
52.207 |
|
|
TOTAL |
2948.732 |
1156.022 |
733.559 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Cost of Materials
Consumed |
1074.452 |
440.120 |
218.382 |
|
|
Purchases of
Stock-in-Trade |
186.958 |
35.142 |
39.210 |
|
|
Changes in inventories of
finished goods, work-in-progress and Stock-in-Trade |
34.957 |
(76.831) |
3.214 |
|
|
Employee benefit expense |
366.464 |
101.700 |
39.240 |
|
|
CSR expenditure |
0.563 |
0.000 |
0.000 |
|
|
Other expenses |
523.540 |
186.894 |
112.924 |
|
|
TOTAL |
2186.934 |
687.025 |
412.970 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION |
761.798 |
468.997 |
320.589 |
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
10.080 |
0.521 |
0.080 |
|
|
|
|
|
|
|
|
PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION |
751.718 |
468.476 |
320.509 |
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
122.936 |
26.124 |
8.445 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS)
BEFORE TAX |
628.782 |
442.352 |
312.064 |
|
|
|
|
|
|
|
Less |
TAX |
214.178 |
150.047 |
93.454 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS)
AFTER TAX |
414.604 |
292.305 |
218.610 |
|
|
|
|
|
|
|
|
EARNINGS IN FOREIGN
CURRENCY |
|
|
|
|
|
F.O.B. Value of Exports |
1130.109 |
615.717 |
496.646 |
|
|
TOTAL EARNINGS |
1130.109 |
615.717 |
496.646 |
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
Raw Materials |
NA |
45.551 |
63.111 |
|
|
Components and spare
parts |
NA |
0.000 |
1.425 |
|
|
Capital Goods |
NA |
0.000 |
2.945 |
|
|
TOTAL IMPORTS |
NA |
45.551 |
67.482 |
|
|
|
|
|
|
|
|
Earnings / (Loss) Per
Share (INR) |
8126.00 |
5729.00 |
4285.00 |
CURRENT MATURITIES
OF LONG TERM DEBT DETAILS
|
Particulars |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Current Maturities of Long term debt |
NA |
NA |
NA |
|
Net cash flows from (used in) operations |
544.401 |
614.154 |
341.292 |
|
Net cash flows from (used in) operating activities |
247.478 |
483.744 |
228.441 |
KEY
RATIOS
EFFICIENCY RATIOS
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Average Collection Days (Sundry
Debtors / Income * 365 Days) |
69.71 |
236.17 |
51.02 |
|
|
|
|
|
|
Account Receivables Turnover (Income / Sundry Debtors) |
5.24 |
1.55 |
7.15 |
|
|
|
|
|
|
Average Payment Days (Sundry Creditors / Purchases * 365 Days) |
141.73 |
576.13 |
182.32 |
|
|
|
|
|
|
Inventory Turnover (Operating Income / Inventories) |
1.57 |
1.37 |
3.95 |
|
|
|
|
|
|
Asset Turnover (Operating Income / Net Fixed Assets) |
0.99 |
0.74 |
4.85 |
LEVERAGE RATIOS
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Debt Ratio ((Borrowing
+ Current Liabilities) / Total Assets) |
0.30 |
0.45 |
0.14 |
|
|
|
|
|
|
Debt Equity Ratio (Total Liability / Networth) |
0.03 |
0.11 |
0.00 |
|
|
|
|
|
|
Current Liabilities to Networth (Current Liabilities / Net Worth) |
0.44 |
0.85 |
0.16 |
|
|
|
|
|
|
Fixed Assets to Networth (Net Fixed Assets / Networth) |
0.50 |
0.57 |
0.08 |
|
|
|
|
|
|
Interest Coverage Ratio (PBIT / Financial Charges) |
75.58 |
900.19 |
4007.36 |
PROFITABILITY RATIOS
|
PARTICULARS |
|
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
PAT to Sales ((PAT
/ Sales) * 100) |
% |
14.15 |
26.72 |
32.08 |
|
|
|
|
|
|
|
Return on Total Assets ((PAT / Total Assets) * 100) |
% |
18.50 |
13.97 |
22.73 |
|
|
|
|
|
|
|
Return on Investment (ROI) ((PAT / Networth) * 100) |
% |
27.09 |
26.20 |
26.58 |
SOLVENCY RATIOS
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Current Ratio (Current
Assets / Current Liabilities) |
1.72 |
1.29 |
5.89 |
|
|
|
|
|
|
Quick Ratio ((Current Assets – Inventories) / Current
Liabilities) |
0.99 |
0.92 |
5.28 |
|
|
|
|
|
|
G-Score Ratio Financial (Networth / Total Assets) |
0.68 |
0.53 |
0.86 |
|
|
|
|
|
|
G-Score Ratio Debt (Debts / Equity Capital) |
98.04 |
235.29 |
0.00 |
|
|
|
|
|
|
G-Score Ratio Liquidity (Total Current Assets / Total Current Liabilities) |
1.72 |
1.29 |
5.89 |
Total
Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term
debts
FINANCIAL ANALYSIS
[all figures are
in INR Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2014 |
31.03.2015 |
31.03.2016 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Share Capital |
0.510 |
0.510 |
0.510 |
|
Reserves & Surplus |
822.090 |
1115.296 |
1529.899 |
|
Net
worth |
822.600 |
1115.806 |
1530.409 |
|
|
|
|
|
|
Long-term borrowings |
0.000 |
0.000 |
0.000 |
|
Short term borrowings |
0.000 |
120.000 |
50.000 |
|
Total
borrowings |
0.000 |
120.000 |
50.000 |
|
Debt/Equity
ratio |
0.000 |
0.108 |
0.033 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2014 |
31.03.2015 |
31.03.2016 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Sales |
681.352 |
1093.759 |
2931.009 |
|
|
|
60.528 |
167.976 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2014 |
31.03.2015 |
31.03.2016 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Sales |
681.352 |
1093.759 |
2931.009 |
|
Profit/ (Loss) |
218.610 |
292.305 |
414.604 |
|
|
32.08
% |
26.72
% |
14.15
% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in
Report (Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
No |
|
5 |
Buyer visit details |
-- |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
Yes |
|
8 |
Designation of contact person |
Yes |
|
9 |
Promoter’s background |
Yes |
|
10 |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11 |
Pan Card No. of Proprietor / Partners |
No |
|
12 |
Voter Id Card No. of Proprietor / Partners |
No |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
No |
|
16 |
No. of employees |
No |
|
17 |
Details of sister concerns |
Yes |
|
18 |
Major suppliers |
No |
|
19 |
Major customers |
No |
|
20 |
Banking Details |
Yes |
|
21 |
Banking facility details |
Yes |
|
22 |
Conduct of the banking account |
-- |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
No |
|
26 |
Turnover of firm for last three years |
Yes |
|
27 |
Reasons for variation <> 20% |
-- |
|
28 |
Estimation for coming financial year |
No |
|
29 |
Profitability for last three years |
Yes |
|
30 |
Major shareholders, if available |
Yes |
|
31 |
External Agency Rating, if available |
No |
|
32 |
Litigations that the firm/promoter
involved in |
-- |
|
33 |
Market information |
-- |
|
34 |
Payments terms |
No |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
STATE OF COMPANY’S AFFAIRS
The Company is inter-alia engaged in the business of manufacturing pharmaceutical products. The Company’s factories located at Goa and Maharashtra are dedicated for manufacturing of Aerosol, Dry Syrup, Liquids, Tablets, Capsules and Dry Powder Injectables Dosage form. The manufacturing facilities have been inspected and approved by the US FDA, MHRA (UK), TGA (Australia), MCC (South Africa), ANVISA (Brazil), PIC (Germany) etc.
UNSECURED LOANS:
|
PARTICULARS |
31.03.2016 INR In Million |
31.03.2015 INR In Million |
|
SHORT TERM BORROWINGS |
|
|
|
Intercorporate
deposits |
50.000 |
120.000 |
|
|
|
|
|
Total |
50.000 |
120.000 |
INDEX OF CHARGES:
|
S No |
SRN |
Charge Id |
Charge Holder Name |
Date of Creation |
Date of Modification |
Date of Satisfaction |
Amount |
Address |
|
1 |
G04055901 |
100028112 |
The Hongkong and Shanghai Banking Corporation Limited |
26/04/2016 |
- |
- |
1000000.0 |
52/60M G Road, Mumbai 400001, Maharashtra, India |
|
2 |
G03639960 |
10605034 |
The Hongkong and Shanghai Banking Corporation Limited |
05/11/2015 |
- |
25/04/2016 |
100000000.0 |
India Area Management Office 52/60 Mahatma Gandhi Road, P.O Box 128 Mumbai 400001, Maharashtra, India |
FIXED ASSETS:
·
Land
·
Building
·
Plant and Machinery
·
Furniture and Fixture
·
Office Equipment
·
Computer
·
Vehicles
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions involving
their assets have been blocked or convicted, found guilty or against whom a
judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No available
information exist that suggest that subject or any of its principals have been
formally charged or convicted by a competent governmental authority for any
financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
INR |
|
US Dollar |
1 |
INR 67.22 |
|
|
1 |
INR 90.88 |
|
Euro |
1 |
INR 80.09 |
INFORMATION DETAILS
|
Information
Gathered by : |
SAV |
|
|
|
|
Analysis Done by
: |
PSD |
|
|
|
|
Report Prepared
by : |
NKT |
SCORE FACTORS
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.